LIVE SESSION BRIEF Diagnostics & Research $2.85B Cap Quant: HOLD

Veracyte, Inc. (VCYT) — Live Session & Technical Brief

Updated Nov 16, 2026 9:00 PM ET · Prev Close $24.33

Pro Workspace
Last Session Price
$24.01 -1.32%
-$0.32 vs $24.33 prior close
Intraday Range
$23.27 – $24.57
Open $23.97
Relative Volume
0.83x Avg
2,188,965 sh
52-Week Range
$21.91 – $60.91
Benchmark Alpha
+0.59% vs SPY
+1.35% vs QQQ
20-Session Trend -46.4%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.32%) in Diagnostics & Research

Veracyte, Inc. (VCYT) is trading within a tight intraday band at $24.01 (-1.32%, 0.83x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, VCYT is outperforming the S&P 500 by +0.59%. 14-day RSI stands at 27.8, keeping momentum in a oversold regime.

NEWS 70% Weight
Veracyte VCYT Reset Decipher Growth Expectations, Is The Discount Now Too Wide?

Why Veracyte Stock Is Back Under The Microscope Veracyte VCYT rattled investors after resetting near term expectations for its Decipher prostate cancer test, even as quarterly revenue growth remained solid and management

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($24.01) trades relative to 20-day SMA ($39.20) and 50-day SMA ($41.79).

Volume Confirmation
LOW VOLUME (0.83x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

VCYT outperforming the S&P 500 by +0.59%
VCYT Session
-1.32%
$24.01
S&P 500 (SPY)
-1.91%
$739.95
Nasdaq 100 (QQQ)
-2.67%
$661.75
Healthcare (XLV)
-0.51%
$187.88
Alpha vs SPY: +0.59% Alpha vs QQQ: +1.35% Alpha vs XLV: -0.81%

Recent VCYT Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$23.15
Short-term support band
Upper Bound
$24.87
Short-term resistance band
Key Inflection Level
$23.27 (session support)

Monitor volume expansion above 1.5x RVOL around $23.27 (session support) for directional breakout confirmation.

Technical Regime (VCYT)

BEARISH MA TREND
RSI (14)
27.8
Oversold
20-Day SMA
$39.20
Below 20d
50-Day SMA
$41.79
Below 50d
MACD Signal
Bearish
MACD -5.84
ADX (14)
42.0
Strong trend
10d Momentum
-24.99
Strong downward 10-day pressure

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 0.1
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

StockTwits messages suggest bullish sentiment on $VCYT, as one trader believes $VCYT will bottom when Apple (APLD) does. The trader also highlights the company's cash position of $370M and stock repurchase plan of $100M, implying a positive outlook.

Reddit communities: 1 comment (Bullish)

About Veracyte, Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal …

Sector
Healthcare
Market Cap
$2.85B
Forward P/E
25.9x
Employees
824

Get Instant VCYT Catalyst Alerts

Receive an email alert when VCYT triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

VCYT Session & Catalyst FAQ

Why is VCYT stock trading near flat today?

Veracyte, Inc. (VCYT) is trading within a tight intraday band at $24.01 (-1.32%, 0.83x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, VCYT is outperforming the S&P 500 by +0.59%. 14-day RSI stands at 27.8, keeping momentum in a oversold regime.

Is VCYT stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.83x relative volume (low participation). Our multi-factor model currently rates VCYT as HOLD. Review full valuation, quality, and timing signals on the VCYT Buy or Sell Decision Brief →

What is VCYT's intrinsic value and expected trading range?

At $24.01, VCYT's modeled 1-to-3 session range is $23.15 – $24.87, with a key inflection level at $23.27 (session support). Compare current price against multi-year cash flow projections in the VCYT Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for VCYT?

RSI at 27.8 indicates oversold conditions — watch for mean-reversion support. VCYT trades at $24.01 relative to its 20-day SMA ($39.20) and 50-day SMA ($41.79), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs